Approval · Notice of Compliance 28558 · 2022
ROCURONIUM BROMIDE INJECTION: Notice of Compliance 28558
Issued July 8, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28558
- Date
- July 8, 2022
- Company
- Eugia Pharma Inc.Woodbridge, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- ROCURONIUMM BROMIDE INJECTION (Sandoz Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROCURONIUM BROMIDE INJECTION | 02528657 | Marketed |
Medicinal ingredients
- ROCURONIUM BROMIDE 10 MG per ML